Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of MEMP1972A in asthma
2010-021170-11Phase 2Completed
- Sponsor
- Genentech
- Start
- Nov 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing MEMP1972A with Placebo (2 arms). Primary endpoint: Late airway response AUC. Started Nov 2010; status: completed.
02
Drugs
quilizumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-021170-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021170-11.